OrsoBio Closes $67 Million Series B Financing to Advance Obesity Therapies
Key Highlights OrsoBio secures $67M Series B financing, led by Ascenta Capital and Woodline Partners. Proceeds will accelerate…
Browsing Tag
Ascenta Capital
2 posts
Odyssey Therapeutics Secures $101 Million in Series C Funding to Propel Immunomodulators and Oncology Medicines
Key Highlights Odyssey Therapeutics, Inc. completes a significant $101 million Series C financing round led by Ascenta Capital. The funding will…